Similar articles for PMID: 26389095

Year	Number of Results
2006	1
2007	2
2009	1
2010	2
2012	3
2013	4
2014	3
2015	9
2016	13
2017	6
2019	3
2020	1
2024	0

1

The risk of pancreatitis with sitagliptin therapy in older adults: a population-based cohort study.

Clemens KK, McArthur E, Fleet JL, Hramiak I, Garg AX. Clemens KK, et al. CMAJ Open. 2015 Apr 2;3(2):E172-81. doi: 10.9778/cmajo.20140060. eCollection 2015 Apr-Jun. CMAJ Open. 2015. PMID: 26389095 Free PMC article.

2

The hypoglycemic risk of glyburide (glibenclamide) compared with modified-release gliclazide.

Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX. Clemens KK, et al. Can J Diabetes. 2015 Nov;39 Suppl 4:32-40. doi: 10.1016/j.jcjd.2015.09.087. Can J Diabetes. 2015. PMID: 26541489

3

The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.

Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX. Clemens KK, et al. Can J Diabetes. 2015 Aug;39(4):308-16. doi: 10.1016/j.jcjd.2015.01.001. Epub 2015 Mar 31. Can J Diabetes. 2015. PMID: 25840942

4

Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.

Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, Radican L. Zhang Q, et al. Curr Med Res Opin. 2010 Jul;26(7):1697-703. doi: 10.1185/03007995.2010.489029. Curr Med Res Opin. 2010. PMID: 20465367

5

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide.

Dore DD, Seeger JD, Arnold Chan K. Dore DD, et al. Curr Med Res Opin. 2009 Apr;25(4):1019-27. doi: 10.1185/03007990902820519. Curr Med Res Opin. 2009. PMID: 19278373

6

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.

Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, Peng L, Hodish I, Bodnar T, Wesorick D, Balakrishnan V, Osei K, Umpierrez GE. Pasquel FJ, et al. Lancet Diabetes Endocrinol. 2017 Feb;5(2):125-133. doi: 10.1016/S2213-8587(16)30402-8. Epub 2016 Dec 8. Lancet Diabetes Endocrinol. 2017. PMID: 27964837 Clinical Trial.

7

Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.

Liao KF, Lin CL, Lai SW, Chen WC. Liao KF, et al. Eur J Intern Med. 2016 Jan;27:76-9. doi: 10.1016/j.ejim.2015.09.015. Epub 2015 Oct 1. Eur J Intern Med. 2016. PMID: 26433909

8

Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan.

Tseng CH. Tseng CH. Ann Med. 2015;47(7):561-9. doi: 10.3109/07853890.2015.1091944. Epub 2015 Oct 1. Ann Med. 2015. PMID: 26426676

9

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.

Inzucchi SE, Tunceli K, Qiu Y, Rajpathak S, Brodovicz KG, Engel SS, Mavros P, Radican L, Brudi P, Li Z, Fan CP, Hanna B, Tang J, Blonde L. Inzucchi SE, et al. Diabetes Obes Metab. 2015 Oct;17(10):956-64. doi: 10.1111/dom.12489. Epub 2015 Jun 22. Diabetes Obes Metab. 2015. PMID: 25962401 Free PMC article.

10

Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.

Tseng CH. Tseng CH. Oncotarget. 2016 Sep 20;7(38):62687-62696. doi: 10.18632/oncotarget.10507. Oncotarget. 2016. PMID: 27409676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year